FindTrial
Sign In

Study to assess safety of Ayurvedic medicine in treatment of chronic illness.

A retrospective observational safety to evaluate safety of Classically prepared Ayurvedic Herbometallic compounds in hetrogenous group of chronically ill patients treated with herbometallic compounds

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/012912
Enrollment
200
Registered
2018-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronically illed patients

Interventions

Intervention1: Herbometallic Ayurvedic Formulations: Herbometallic ayurvedic formulations containing processed and incineration metals as active pharmaceutical ingredients. Duration: Safety p

Sponsors

Rasayani Cancer Clinics Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and Female patients with age 18-50 years. Patient consuming herbometallic formulation since from more than three months

Exclusion criteria

Exclusion criteria: 1.patient suffering from renal disorders 2. Patient suffering from hepatic disorders 3. Patient suffering from diabeties and hypertension.

Design outcomes

Primary

MeasureTime frame
Cross sectional evaluation of CBC, Renal function test and liver function test for any abnormality.Timepoint: Crosssectional assessment of safety parameter at one time point in patients who took ayurvedic medicines for more than three months.—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDr Poonam Birari

Rasayu Cancer Clinic, Pune.

poonam.birari84@gmail.com02024537149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026